oprelvekin
Formulary status restricted to hematology/oncology. Monitor for platelet count recovery so this drug can be discontinued in a timely manner as appropriate. Cost is approximately $250 a day.
Reviewed: June 27, 2006
Formulary status restricted to hematology/oncology. Monitor for platelet count recovery so this drug can be discontinued in a timely manner as appropriate. Cost is approximately $250 a day.
Reviewed: June 27, 2006